Acute and fatal cardiotoxicity following high-dose cyclophosphamide in a patient undergoing autologous stem cell transplantation for systemic sclerosis despite satisfactory cardiopulmonary screening

Bone Marrow Transplant. 2017 Dec;52(12):1674-1677. doi: 10.1038/bmt.2017.188. Epub 2017 Sep 4.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Autografts
  • Cardiotoxicity* / blood
  • Cardiotoxicity* / etiology
  • Cardiotoxicity* / pathology
  • Cyclophosphamide* / administration & dosage
  • Cyclophosphamide* / adverse effects
  • Fatal Outcome
  • Female
  • Humans
  • Middle Aged
  • Scleroderma, Systemic* / blood
  • Scleroderma, Systemic* / pathology
  • Scleroderma, Systemic* / therapy
  • Stem Cell Transplantation*

Substances

  • Cyclophosphamide